The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis

Current Rheumatology Reports

Volumn 11, Issue 4, 2009, Pages 233-234

  Kavanaugh, Arthur ^a  

^a Thornton Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR; USTEKINUMAB;

ARTHRITIS; ARTHROPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HUMAN; IMMUNOPATHOGENESIS; LOW DRUG DOSE; MORNING STIFFNESS; NOTE; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT;

EID: 70449637642     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0043-z     Document Type: Note

References (7)

1. D.D. Gladman 2002 Current concepts in psoriatic arthritis Curr Opin Rheumatol 14 361 370 12118168 10.1097/00002281-200207000-00005 (Pubitemid 34693978)
2. N.J. McHugh C. Balachrishnan S.M. Jones 2003 Progression of peripheral joint disease in psoriatic arthritis: a 5-year prospective study Rheumatology (Oxford) 42 778 783 10.1093/rheumatology/keg217 1:STN:280:DC%2BD3s3kvVGltA%3D%3D (Pubitemid 37220911)
3. P.J. Mease A.J. Kivitz F.X. Burch, et al. 2004 Etanercept treatment of psoriatic arthritis: safety, efficacy and effect on disease progression Arthritis Rheum 50 2264 2272 15248226 10.1002/art.20335 1:CAS:528: DC%2BD2cXmsVansbc%3D (Pubitemid 38924405)
4. C. Antoni G.G. Krueger K. de Vlam, et al. 2005 Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial Ann Rheum Dis 64 1150 1157 15677701 10.1136/ard.2004.032268 1:CAS:528:DC%2BD2MXpslGmsrg%3D (Pubitemid 41113349)
5. P.J. Mease D.D. Gladman C.T. Ritchlin, et al. 2005 Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial Arthritis Rheum 52 3279 3289 16200601 10.1002/art.21306 1:CAS:528:DC%2BD2MXhtF2msrjP (Pubitemid 41447111)
6. G.C. Krueger R.G. Langley C.L. Leonardi, et al. 2007 A human interleukin 12/23 monoclonal antibody for the treatment of psoriasis N Engl J Med 356 580 592 17287478 10.1056/NEJMoa062382 1:CAS:528:DC%2BD2sXhsFOksbo%3D (Pubitemid 46220818)
7. C.L. Leonardi A.B. Kimball K.A. Papp, et al. 2008 Efficacy and safety of ustekimumab, a human interleukin 12/23 monoclonal antibody in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1) Lancet 371 1665 1674 18486739 10.1016/S0140-6736(08)60725-4 1:CAS:528:DC%2BD1cXlvFymt7o%3D (Pubitemid 351671883)